● With regards to fundamentals, the enterprise value to sales ratio is at 0.65 for the current period. Therefore, the company is undervalued.
● The company appears to be poorly valued given its net asset value.
● The company has a low valuation given the cash flows generated by its activity.
● This company will be of major interest to investors in search of a high dividend stock.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 61.11 times its estimated earnings per share for the ongoing year.
● For the past year, analysts have significantly revised downwards their profit estimates.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● Over the past twelve months, analysts' consensus has been significantly revised downwards.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.